You have access
Efficacy and Safety of Palbociclib and Fulvestrant in Japanese Patients With ER+/HER2− Advanced/Metastatic Breast Cancer
HIROHITO SEKI, TAKASHI SAKURAI, YUKA MAEDA, NAOHIKO OKI, MINA AOYAMA, RYOU YAMAGUCHI, TOSHIKI TOKUDA, TAKUJI KABURAGI, TAKEHIRO OKUMURA, TSUYOSHI KARAHASHI, KENICHIRO NAKAJIMA, KAORI HIGETA and KEN SHIMIZU
In Vivo November 2019, 33 (6) 2037-2044; DOI: https://doi.org/10.21873/invivo.11701
